A comparison of insight into clinical symptoms versus insight into neuro-cognitive symptoms in schizophrenia

Schizophrenia Research

Volumn 118, Issue 1-3, 2010, Pages 134-139

  Medalia, Alice ^a   Thysen, Julie ^b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Awareness; Cognition; Insight; Neuro cognition; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BRIEF ASSESSMENT INTO COGNITION IN SCHIZOPHRENIA; CLINICAL ASSESSMENT; COGNITION; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASURE OF INSIGHT INTO COGNITION CLINICIAN RATED; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCALE TO ASSESS THE UNAWARENESS OF MENTAL DISORDER REVISED; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYMPTOM; WIDE RANGE ACHIEVEMENT TEST;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 77951974632     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.09.027     Document Type: Article

References (35)

1. Aleman A., Agrawal N., Morgan K., David A.S. Insight in psychosis and neuropsychological function: meta-analysis. Br. J. Psychiatry 2006, 189(3):204-212.
2. Amador X., Gorman J. Psychopathologic domains and insight in schizophrenia. Psychiatr. Clin. North Am. 1998, 21(1):27-42.
3. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. Am. J. Psychiatry 1993, 150(6):873-879.
4. Bartko G., Herczeg I., Zador G. Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatr. Scand. 1988, 77(1):74-76.
5. Beck A.T., Baruch E., Balter J.M., Steer R.A., Warman D.M. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr. Res. 2004, 68(2-3):319-329.
6. Cabeza I.G., Amador M.S., Lopez C.A., de Chavez M.G. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors. Schizophr. Res. 2000, 41(2):349-355. Christina M. Kitchen, Stephanie M. Woo, Jim Mintz.
7. Cooke M.A., Peters E.R., Kuipers E., Kumari V. Disease, deficit or denial? Models of poor insight in psychosis. Acta. Psychiatr. Scand. 2005, 112(1):4-17.
8. Cuesta M.J., Peralta V., Zarzuela A. Reappraising insight in psychosis: Multi-scale longitudinal study. Br. J. Psychiatry 2000, 177(3):233-240.
9. Dunning D., Health C., Suls J.M. Flawed self-assessment: implications for health, education, and the workplace. Psychol. Sci. Public Interest 2004, 5:69-106.
10. Gladsjo J.A., Heaton R.K., Palmer B.W., Taylor M.J., Jeste D.V. Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J. Int. Neuropsychol. Soc. 1999, 5:247-254.
11. Gold J.M., Harvey P.D. Cognitive deficits in schizophrenia. Psychiatr. Clin. North Am. 1993, 16(2):295-312.
12. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 1996, 153(3):321-330.
13. Harvey P.D., Serper M.R., White L., Parrella M.J., McGurk S.R., Moriarty P.J., Bowie C., Vadhan N., Friedman J., David K.L. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Compr. Psychiatry 2001, 42(4):306-313.
14. Henry C., Ghaemi S.N. Insight in psychosis: a systematic review of treatment interventions. Psychopathology 2004, 37(4):194-199.
15. Kamali M., Kelly L., Gervin M, Borwne S., Larkin C., O'Callaghan E. Insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr. Serv. 2001, 52(2):161-163.
16. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenor L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 2004, 68(2-3):283-297.
17. Keefe R.S.E., Poe M., Walker T.M., Kang J.W., Harvey P.D. The schizophrenia cognition rating scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am. J. Psychiatry 2006, 163(3):426-432.
18. Kemp R., David A. Psychological predictors of insight and compliance in psychotic patients. Br. J. Psychiatry 1996, 169(4):444-450.
19. Lyman H.B. Test Scores and What They Mean 1971, Prentice-Hall, Inc., New Jersey. 2nd ed.
20. Lysacker P., Bell M. Insight and cognitive impairment in schizophrenia performance on repeated administrations of the Wisconsin Card Sorting Test. J. Nerv. Ment. Dis. 1994, 182(11):656-660.
21. McEvoy J.P., Apperson L.J., Appelbaum P.S., Ortlip P., Brecosky J., Hammill K., Geller J.L., Roth L. Insight in schizophrenia: its relationship to acute psychopathology. J. Nerv. Ment. Dis. 1989, 177(1):42-47.
22. Medalia A., Lim R. Self-awareness of cognitive functioning in schizophrenia. Schizophr. Res. 2004, 71(2-3):331-338.
23. Medalia A., Thysen J. Insight into neuro-cognitive dysfunction in schizophrenia. Schizophr. Bull. 2008, 34(6):1221-1230.
24. Medalia A., Thysen J., Freilich B. Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?. Schizophr. Res. 2008, 105(1-3):156-164.
25. Medalia A., Choi J., Schwalbe E., King E. Efficacy of a brief intervention to improve awareness of neurocognitive deficit in schizophrenia. Schizophr. Bull. 2009, 35(sup 1):351.
26. Mintz A.R., Dobson K.S., Romney D.M. Insight in schizophrenia: a meta-analysis. Schizophr. Res. 2003, 61(1):75-88.
27. Moritz S., Ferahli S., Naber D. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated function with neuropsychological test results. J. Int. Neuropsychol. Soc. 2004, 10:623-633.
28. Niendam T.A., Bearden C.E., Johnson J.K., McKinley M., Loewy R., O'Brien M., Nuechterlein K.H., Green M.F., Cannon T.D. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr. Res. 2006, 84(1):100-111.
29. Sanjuan J., Aguilar E.J., Olivares J.M., Ros S., Montejo A.L., Mayoral F., Gonzalez-Torres M.A., Bousoño M. Subjective perception of cognitive deficit in psychotic patients. J. Nerv. Ment. Dis. 2006, 194(1):58-60.
30. Smith C.M., Barzman D., Pristach C.A. Effect of patient and family insight on compliance of schizophrenic patients. J. Clin. Pharmacol. 1997, 37(2):147-154.
31. Stip E., Caron J., Renaud S., Pampoulova T., Lecomte Y. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. Compr. Psychiatry 2003, 44(4):331-340.
32. Subotnik K.L., Nuechterlein K.H., Irzhevsky V., Kitchen C.M., Woo S.M., Mintz J. Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem?. Schizophr. Res. 2005, 75(2-3):147-157.
33. Thompson K.N., McGorry P.D., Harrigan S.M. Reduced awareness of illness in first-episode psychosis. Compr. Psychiatry 2001, 42(6):498-503.
34. Young D.A., Davila R., Scher H. Unawareness of illness and neuropsychological performance in chronic schizophrenia. Schizophr. Res. 1993, 10(2):117-124.
35. Young D.A., Campbell Z., Zakzanis K.K., Weinstein E. A comparison between an interview and a self-report method of insight assessment in chronic schizophrenia. Schizophr. Res. 2003, 63(1-2):103-109.